F.D.A. Delays Action on Closely Watched Alzheimer’s Drug
Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy. [Source]
Publication Date:Origin: nytimes.com
Category: Drugs (Pharmaceuticals)
Topics: efficacy, safety, drug’s, evaluate, experts, independent, panel, convene, decided, agency, month, approved, expected, donanemab, Lilly’s, Alzheimer’s, Watched, Closely, Action, Delays
Source: https://www.nytimes.com/2024/03/08/health/alzheimers-drug-donanemab.html